Related references
Note: Only part of the references are listed.Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine
Radia Hassan et al.
BRIEFINGS IN BIOINFORMATICS (2021)
The role of pharmacogenomics in adverse drug reactions
Ramon Cacabelos et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature
Susel Gongora Alonso et al.
JOURNAL OF MEDICAL SYSTEMS (2019)
Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies
Silvia Vilches et al.
PHARMACEUTICS (2019)
Pharmacogenomics Prescribing Precisely
Dyson T. Wake et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel
Chad Bousman et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
Catriona Hippman et al.
JOURNAL OF PERSONALIZED MEDICINE (2019)
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
Kristi Krebs et al.
HUMAN GENOMICS (2019)
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century
Sarah Watson et al.
ECLINICALMEDICINE (2019)
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects
Simona Volpi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
Elizabeth J. Phillips et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
The Genetics of Food Allergy
Cristina A. Carter et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2018)
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors
Corine Ekhart et al.
DRUG SAFETY (2018)
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing
Susanne B. Haga et al.
HEALTH AFFAIRS (2018)
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
Kathrin Blagec et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2018)
Patient perspectives following pharmacogenomics results disclosure in an integrated health system
Amy A. Lemke et al.
PHARMACOGENOMICS (2018)
Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials
Chiara Fabbri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care
K. N. Lazaridis
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J. Caraballo et al.
GENETICS IN MEDICINE (2017)
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
Kelly E. Caudle et al.
GENETICS IN MEDICINE (2017)
Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
S. J. Bielinski et al.
PHARMACOGENOMICS JOURNAL (2017)
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies
Joshua D. Rosenblat et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions
Michelle E. Klein et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Mafalda M. Dias et al.
PHARMACEUTICAL RESEARCH (2017)
Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory
Teresa T. Vo et al.
PHARMACOTHERAPY (2017)
Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder
Kimberly Peterson et al.
PSYCHOPHARMACOLOGY (2017)
The challenges of implementing pharmacogenomic testing in the clinic
Ann M. Moyer et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses
Hai-Yan He et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
J. A. Luzum et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe
Mengfei Lu et al.
BMC MEDICAL GENOMICS (2017)
Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development
Marc Hinderer et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2017)
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C. H. van der Wouden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The value of routine pharmacogenomic screeningAre we there yet? A perspective on the costs and benefits of routine screeningshouldn't everyone have this done?
D. L. Veenstra
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Review of Commercially Available Epilepsy Genetic Panels
Chelsea Chambers et al.
JOURNAL OF GENETIC COUNSELING (2016)
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
Henry M. Dunnenberger et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Genetic Variation Among 82 Pharmacogenes: The PGRNseq Data From the eMERGE Network
W. S. Bush et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Precision medicine, genomics and drug discovery
Lon R. Cardon et al.
HUMAN MOLECULAR GENETICS (2016)
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions
Catrin O. Plumpton et al.
PHARMACOECONOMICS (2016)
Patient experiences with pharmacogenetic testing in a primary care setting
Susanne B. Haga et al.
PHARMACOGENOMICS (2016)
Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
Sun-Mi Cho et al.
YONSEI MEDICAL JOURNAL (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Pharmacogenomics in the clinic
Mary V. Relling et al.
NATURE (2015)
Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders
Gregory P. Hess et al.
GENETICS RESEARCH (2015)
Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing
A. C. J. W. Janssens et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Evidence Required to Demonstrate Clinical Utility of Pharmacogenetic Testing: The Debate Continues
N. K. Gillis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Kelly E. Caudle et al.
CURRENT DRUG METABOLISM (2014)
The EGAPP initiative: lessons learned
Ned Calonge et al.
GENETICS IN MEDICINE (2014)
Points to Consider in the Clinical Use of NGS Panels for Mitochondrial Disease: An Analysis of Gene Inclusion and Consent Forms
Julia Platt et al.
JOURNAL OF GENETIC COUNSELING (2014)
Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time-Using Genomic Data to Individualize Treatment Protocol
Suzette J. Bielinski et al.
MAYO CLINIC PROCEEDINGS (2014)
Cost-effectiveness of genotyping to guide treatment
Michael J. Sorich et al.
PHARMACOGENOMICS (2014)
Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review
Sarah Cargnin et al.
PHARMACOGENOMICS (2014)
Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia
M. M. Dias et al.
PHARMACOGENOMICS JOURNAL (2014)
Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
M. J. Sorich et al.
PHARMACOGENOMICS JOURNAL (2014)
Stakeholder Views on Pharmacogenomic Testing
Haridarshan N. Patel et al.
PHARMACOTHERAPY (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Challenges and Limitations in the Interpretation of Systematic Reviews: Making Sense of Clopidogrel and CYP2C19 Pharmacogenetics
M. J. Sorich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
S. G. Leckband et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Genomic Biomarkers for Personalized Medicine: Development and Validation in Clinical Studies
Shigeyuki Matsui
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2013)
The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency
Wendy S. Rubinstein et al.
NUCLEIC ACIDS RESEARCH (2013)
CFH and ARMS2 Genetic Polymorphisms Predict Response to Antioxidants and Zinc in Patients with Age-related Macular Degeneration
Carl C. Awh et al.
OPHTHALMOLOGY (2013)
Pharmacogenetics in major depression: A comprehensive meta-analysis
Tomihisa Niitsu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Solid-State Nanopore Detection of Protein Complexes: Applications in Healthcare and Protein Kinetics
Kevin J. Freedman et al.
SMALL (2013)
Adverse Drug Reaction Deaths Reported in United States Vital Statistics, 1999-2006
Greene Shepherd et al.
ANNALS OF PHARMACOTHERAPY (2012)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacogenomics and Individualized Medicine: Translating Science Into Practice
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
E. J. Stanek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
More Codeine Fatalities After Tonsillectomy in North American Children
Lauren E. Kelly et al.
PEDIATRICS (2012)
Survey of US public attitudes toward pharmacogenetic testing
S. B. Haga et al.
PHARMACOGENOMICS JOURNAL (2012)
Pharmacogenomics The Genetics of Variable Drug Responses
Dan M. Roden et al.
CIRCULATION (2011)
Pharmacogenetic Testing: Time for Clinical Practice Guidelines
U. Amstutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Pharmacogenetics: From Bench to Byte-An Update of Guidelines
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Genetics of the HLA Region in the Prediction of Type 1 Diabetes
Janelle A. Noble et al.
CURRENT DIABETES REPORTS (2011)
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics
Laurent Becquement et al.
PHARMACOGENOMICS (2011)
Outcomes of interest in evidence-based evaluations of genetic tests
Jeffrey R. Botkin et al.
GENETICS IN MEDICINE (2010)
Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
Rena Conti et al.
MEDICAL DECISION MAKING (2010)
Application of a pharmacogenetic test adoption model to six oncology biomarkers
Hawazin Faruki et al.
PERSONALIZED MEDICINE (2010)
CYP2D6 Genotyping for Functional-Gene Dosage Analysis by Allele Copy Number Detection
Naoya Hosono et al.
CLINICAL CHEMISTRY (2009)
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2009)
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
Steven M. Teutsch et al.
GENETICS IN MEDICINE (2009)
Codeine and morphine pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
Bruce R. Schackman et al.
AIDS (2008)
PharmGKB: UNDERSTANDING THE EFFECTS OF INDIVIDUAL GENETIC VARIANTS
Katrin Sangkuhl et al.
DRUG METABOLISM REVIEWS (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Russell A. Wilke et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Drug metabolism and pharmacogenetics: the British contribution to fields of international significance
J Caldwell
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital
Jimmy Jose et al.
PHARMACOLOGICAL RESEARCH (2006)
The AmpliChip (TM) CYP450 Genotyping Test - Integrating a new clinical tool
Jose de Leon et al.
MOLECULAR DIAGNOSIS & THERAPY (2006)
Adverse drug reactions in elderly patients
PA Routledge et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Pharmacogenetics - five decades of therapeutic lessons from genetic diversity
UA Meyer
NATURE REVIEWS GENETICS (2004)
CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR
E Schaeffeler et al.
HUMAN MUTATION (2003)
Delayed pharmacological effects of antidepressants
A Frazer et al.
MOLECULAR PSYCHIATRY (2002)
How many deaths occur annually from adverse drug reactions in the United States?
PA Chyka
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
